INTRODUCTION
============

Nowdays colonoscopy is the most useful exam for evaluation of colonic mucosa. The indications include investigation for intestinal bleeding, changes in the bowel habits and colorectal cancer screening.

In the colonoscopy the success depends on the quality of the bowel preparation that aims to empty the colon of all fecal material, permitting adequate visualization of the mucosal surface. The preparation of the colon is considered an appropriate factor directly associated to the correct diagnostic, lower chance of complications, low cost and patients complaints.

The preference is oral preparation - except for the suspected bowel obstruction and temporary ileostomy - for its simplicity and better efficacy compared to enemas requiring introduction of tubes or rectal probes. It is different, according to the type and dose of laxative, the volume of fluid to be ingested and the diet. More recent studies have observed other parameters, like taste, electrolyte supplementation, administration times and doses division.^[@r01]^

The ideal preparation should cleanse the colon quickly without causing histological changes in the mucosa, be at low cost and free or with minimal side effects, such as abdominal discomfort and electrolyte changes. Depending on the drug used, the anterograde preparation induces peristalsis and intestinal spasms responsible for symptoms, such as cramping and bloating, and induces watery diarrhea with electrolyte losses (thirst, dizziness, asthenia, postural hypotension) and anal discomfort. The preparation intolerance (nausea and vomiting) is usually associated with the volume of fluid consumed and the taste.

The ideal laxative should be on reduced volume, palatable, with minimal side effects and low cost. No laxative includes all criteria, and so there are many colon preparations to be administered according to the clinical situation. Recent consensus have demonstrated the efficacy and safety of different formulations, including polyethylene glycol, but this one with the administration disadvantage to drink at four liters^[@r02]^. Lactulose is a laxative described for medical treatment of hepatic encephalopathy in patients with cirrhosis, as well as constipation. Its use in bowel preparation for colonoscopy is considered effective with similar results when compared to manitol^[@r03]^.

In a recent review, a list with several medications and different forms of bowel preparation can be appreciated^1.^ Drugs such as sodium phosphate, polyethylene glycol and sodium picosulfate magnesium citrate underwent several randomized studies in order to verify the effectiveness and tolerance. No study compared polyethylene glycol and lactulose.

Polyethylene glycol (Muvinlax ® or Nulytely ®) is a non-absorbable solution electrolytic and does not induce mucus secretion of electrolytes or reduce significant exchange of fluid in colonic lumen. It has been shown to be nontoxic and can be ingested in large quantities without dangerous effects^[@r03],[@r04]^. It´s use is relatively safe in patients with renal failure, with cirrhosis or congestive heart failure^[@r03]^. The main disadvantage is the need of drinking a lot of liquids (four liters). Although it is effective, it is associated with intolerance in up to 15% of patients. Recent studies with low dose (two liters) when associated with bisacodyl and magnesium citrate have shown better tolerance^[@r03]^. The usual dosage is 240 ml of the product diluted in water (as manufacturers\' orientations) every ten minutes until clear liquid goes out through the anus at maximum intake of four liters. It is recommended not to eat solid food before ingestion of the solution. The dose by nasogastric probe is 20 to 30 ml per minute (1.2-1.8 l/h)^[@r03]^.

Lactulose (Duphalac ®) is a disaccharide, semi-synthetic derivative of lactose. It is absorbed and undergoes bacterial action, which causes fermentation, acidifying the environment and causing acceleration of intestinal transit by stimulating motility^[@r03]^. Another consequence of acidification is increased osmotic pressure within the lumen of the colon, proportional to the dose^[@r04]^. Regarding dosage, 120 ml is diluted with juice or clear water to make 1000 ml swallowing all volume within 1 h^[@r05]^.

Use of lactulose for colon preparation in doses of 10% and 50% showed similar efficacy compared to 10% mannitol^[@r05]^. In a study of 2000 consecutive patients, the lactulose with above way of administration showed efficacy good in 84.8%, fair in 9.2% and poor in 5.9% of cases. The preparation intolerance (inability to drink all the solution) was observed in 3.3% of patients. So, studies to evaluate the efficacy, tolerance and cost comparing polyethyleneglycol and lactulose in the colon preparation may contribute to the routine of patients undergoing colonoscopies.

The objective of this study was to performed a prospective double-blind study, comparing the above two types of solutions for bowel preparation analyzing tolerance, symptoms, complications and efficacy.

METHODS
=======

This study was conducted at Hospital Santa Casa de Curitiba, Brazil from January 2011 to January 2012. After the review and approval of the institution\'s Research Ethics Committee, 200 patients were selected from the Brazilian National Health System referred to elective colonoscopy performed in Endoscopy Service of Santa Casa de Misericórdia de Curitiba. They were informed about the bowel preparation based on lactulose or polyethylene glycol. To each patient randomly selected was given a box containing one of the two preparations, double-blindly done. The product label was covered and the patients received specific instructions for preparation without the presence of the researchers. Each box was labeled with a number and recorded on a record that was held closed by the researchers, who only opened the envelope in case of any problem related to the preparation and statistical evaluation at the end of the study. Patients considered eligible for the study signed an informed consent. They had free will to choose or not to enter the trial. Patients who did not wanted to be enrolled received the usual preparation.

As inclusion criteria, the patient was considered eligible when had clinical conditions to oral bowel preparation. Exclusion criteria were patients with ileostomy, with prior colonic resection, with excluded colonic segment, suspected of bowel obstruction, severely ill, unable to oral intake, aged below 13 years old, weighing less than 50 kg, pregnant and those who refuse to participate in the study.

Two evaluations were performed, one at least three days before the colonoscopy and the other on the day of the study. The first evaluation, consisted of a questionnaire to collect data, in which questions about the reason for the examination, digestive symptoms, morbid history and current health status were formulated and maintained closed. The second evaluation, consisted of questions related to bowel preparation, also maintained closed. The colonoscopy was performed in the usual way. The findings during colonoscopy and the quality of the preparation were recorded with standardized scale based on visual estimation of fecal residues observed during the exam ([Figure 1](#t01){ref-type="table"}).

###### 

Scale of quality for bowel preparation

  Scale        Quality of bowel preparation
  ------------ ---------------------------------------------------------------------------------------------------------------------
  Excellent    Small amount of clear liquid or more than 95% of mucosa visualization
  Good         Large volume of clear liquid covering 5 to 25% of the mucosa, but with visualization of more than 90% of the mucosa
  Regular      Some aspirate feces or soft stools permitting visualization of at least 90% of the mucosa
  Bad          Feces not subject to washing or aspiration, permitting visualization of less than 90% of the mucosa
  Inadequate   Bowel preparation incompatible with the exam needing to be repeated after appropriate preparation

RESULTS
=======

The main colonoscopy indications were alterations in bowel habits and abdominal pain. Sixty percent of patients had comorbidities, being hypertension the most prevalent; 10% of those receiving lactulona and 4% who received polyethylene glycol failed to complete the preparation; 50% considered the taste of the preparation \"bad, but tolerable\" - mainly those receiving lactulona. The most common subjective symptoms after preparation was nausea, especially after lactulona. During the exam, most users of lactulona had \"mild\" discomfort, and those using polyethylene glycol felt discomfort as \"tolerable\". The quality of the preparation according to the scale of Aronchick was \"good\" in 75%, regardless of the preparation used. Thus, polyethylene glycol showed better tolerance when compared to lactulona, with no difference in quality of the preparation ([Figure 2](#f01){ref-type="fig"}).
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DISCUSSION
==========

The bowel preparation for colonoscopy is vital for good visualization of the mucosa of the evaluated segments. This procedure must be performed in appropriate way, with low discomfort for patients and high accuracy. The anterograde (oral) administration is more frequently used, and may induce strong peristalsis, cramping, bloating, diarrhea, among others symptoms. The preparation intolerance is common and is usually associated with the volume of fluid consumed and the taste of the solution.

No laxative has all the characteristics of an ideal medication (low volume, palatable, with minimal side effects and low cost).

Among the more frequently used preparations are polyethylene glycol, lactulose, mannitol, with their specific advantages and disadvantages. It becomes necessary, therefore, a detailed analysis of each solution trying to use the best in the various clinical situations that the doctors are faced.

CONCLUSIONS
===========

Lactulona was considered less tolerable by the patients in bowel preparation compared to polyethylene glycol; both have the same quality in the preparation for the exam.
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